Free Trial

Kindly MD (KDLY) Competitors

Kindly MD logo
$0.97 +0.06 (+6.92%)
(As of 09:39 AM ET)

KDLY vs. MRAI, CCM, OPGN, PMD, TOI, BRTX, OTRK, ATIP, MGRX, and ATPC

Should you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Marpai (MRAI), Concord Medical Services (CCM), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), BioRestorative Therapies (BRTX), Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry.

Kindly MD vs.

Kindly MD (NASDAQ:KDLY) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, community ranking, analyst recommendations, earnings and media sentiment.

Kindly MD has a net margin of 0.00% compared to Marpai's net margin of -85.70%.

Company Net Margins Return on Equity Return on Assets
Kindly MDN/A N/A N/A
Marpai -85.70%N/A -100.23%

In the previous week, Marpai had 1 more articles in the media than Kindly MD. MarketBeat recorded 3 mentions for Marpai and 2 mentions for Kindly MD. Marpai's average media sentiment score of 0.30 beat Kindly MD's score of -0.14 indicating that Marpai is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kindly MD
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Marpai
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kindly MD has higher earnings, but lower revenue than Marpai.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kindly MDN/AN/AN/AN/AN/A
Marpai$37.15M0.61-$28.75M-$2.64-0.62

49.8% of Marpai shares are held by institutional investors. 50.5% of Kindly MD shares are held by company insiders. Comparatively, 61.3% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Marpai has a consensus target price of $6.00, indicating a potential upside of 265.85%. Given Marpai's stronger consensus rating and higher possible upside, analysts plainly believe Marpai is more favorable than Kindly MD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kindly MD
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Marpai received 2 more outperform votes than Kindly MD when rated by MarketBeat users.

CompanyUnderperformOutperform
Kindly MDN/AN/A
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

Summary

Marpai beats Kindly MD on 9 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KDLY vs. The Competition

MetricKindly MDHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$5.82M$652.95M$5.07B$8.90B
Dividend YieldN/A1.94%4.99%4.07%
P/E RatioN/A22.3987.8613.46
Price / SalesN/A4.441,228.8287.66
Price / CashN/A25.4439.5136.27
Price / Book1.682.796.946.30
Net IncomeN/A-$10.72M$119.12M$225.93M
7 Day Performance5.63%-1.16%-1.84%-1.32%
1 Month Performance-27.39%-2.51%-3.65%0.60%
1 Year PerformanceN/A387.32%31.64%26.23%

Kindly MD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KDLY
Kindly MD
0.1582 of 5 stars
$0.97
+6.9%
N/AN/A$5.82MN/A0.00N/AGap Up
MRAI
Marpai
2.0113 of 5 stars
$1.64
+13.1%
$6.00
+265.9%
+80.2%$22.53M$37.15M-0.62150
CCM
Concord Medical Services
0.3453 of 5 stars
$4.35
-3.3%
N/A-58.6%$18.88M$75.69M0.00970Gap Up
OPGN
OpGen
N/A$1.99
+1.5%
N/A-55.8%$16.64M$3.42M0.00100News Coverage
PMD
Psychemedics
0.5329 of 5 stars
$2.33
-0.4%
N/A+11.0%$13.72M$22.10M-4.57140
TOI
Oncology Institute
2.3174 of 5 stars
$0.13
-0.9%
$2.50
+1,808.4%
-94.1%$9.89M$324.24M0.00660Gap Down
High Trading Volume
BRTX
BioRestorative Therapies
3.7191 of 5 stars
$1.41
+0.9%
$18.00
+1,174.9%
-22.2%$9.77M$150,000.00-0.927Analyst Revision
News Coverage
Gap Up
OTRK
Ontrak
2.7304 of 5 stars
$1.81
-1.1%
$45.00
+2,386.2%
-79.4%$7.64M$12.74M0.00250Gap Down
ATIP
ATI Physical Therapy
0.224 of 5 stars
$1.62
+1.9%
N/A-78.2%$7.14M$699.02M0.005,600
MGRX
Mangoceuticals
0.508 of 5 stars
$2.39
-3.2%
N/A-98.1%$5.95M$730,000.000.003Gap Down
ATPC
Agape ATP
0.013 of 5 stars
$1.44
+2.9%
N/A-92.4%$5.75M$1.43M0.0040

Related Companies and Tools


This page (NASDAQ:KDLY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners